ArticleJournal of mid-life health
EuroQoL-Visual Analog Scale as a Tool for Assessing Health Status in Breast Cancer Patients: A Cross-sectional Study.
Article in Journal of mid-life health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Breast cancer significantly influences women's health and overall well-being, necessitating comprehensive assessments to guide effective supportive care during cancer treatment. This study utilizes the EuroQoL-Visual Analog Scale (EQ-VAS) to systematically evaluate the health status and quality of life in women undergoing treatment for breast cancer. Materials and Methods: A study was conducted on a sample of 100 patients with breast cancer who were treated at a tertiary care hospital in New Delhi. The EQ-VAS, a part of the EuroQoL five-dimension instrument, was used to evaluate the participants. It measures the participants' self-rated health on a vertical visual analog scale, with 0 representing the worst possible health and 100 representing the best health. Results: The participants' mean EQ-VAS score was 46.95 (standard deviation = 9.4), which denotes low self-perceived health. There were notable differences in EQ-VAS ratings between the various stages of breast cancer, with advanced stages exhibiting lower scores. Patients who underwent surgery for breast cancer were reported with high EQ-VAS scores (52.00 ± 16.71). Conclusion: The results emphasize the different health experiences of women suffering from breast cancer and the value of individualized care programs during cancer care. The EQ-VAS has shown to be a valuable instrument for gathering patient self-perceived health status, providing important information for healthcare professionals to improve supportive care and the overall health of women struggling with breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.